Navigation Links
The MedZilla Report for April 2010 - Pharma Layoffs Drop Below 400 in March; Health Care Adds Another 27,000 Jobs
Date:4/15/2010

Analysts are saying that the U.S. is turning the corner on jobs, with the worst behind us. With only 308 job cuts announced in the pharmaceutical industry in March, 27,000 new health care jobs being added, and a steady unemployment rate for two years running, they may just be correct.

(Vocus) April 15, 2010 -- If the absence of bad news can be considered good news, then it is good news indeed that the pharmaceutical industry only reported 308 job losses in March. That information from outplacement research firm Challenger, Gray & Christmas, combined with an increase of 27,000 jobs in health care (and 631,000 since the recession began in December 2007), gave job seekers hope heading into the second quarter of 2010. The U.S. Bureau of Labor Statistics also reported that the country's unemployment rate held steady at 9.7 percent for the second month in a row.

Many market analysts surveyed by the Associated Press indicated their belief that the U.S. job market is finally turning a corner, and research from MedZilla.com, the internet's leading source for pharmaceutical, biotechnology, and health care job information, seems to be bearing that up. In several states, significant monthly increases were made in candidate searches by companies. The highest jump was in Texas -- almost eight percent -- and five more states plus the United Kingdom all went up by more than two percent. The largest drop was in Georgia -- almost six percent. Of the candidates being sought, more than six percent are likely to be for research positions.
   
The largest geographical increase in job postings took place in Massachusetts, which saw almost 3.5 p
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. The MedZilla Report for March 2010 - Layoffs Down in February Despite Merck Merger; Health Care Employment Up Again
2. The MedZilla Report for February 2010 - Health Care Growth Slows; Big Pharma May Cut Thousands as Sales Landscape Changes
3. The MedZilla Report for January 2010 - Health Care Closes 2009 Strong, But Pharma Continues Shedding Jobs
4. The MedZilla Report for November 2009 - Healthcare Employment Up, And No Major Bad News for Pharma, Either
5. The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close
6. The MedZilla Report for September 2009 - Care Grows Again in September and - Surprisingly - Pharma Sales Jobs Up Too
7. The MedZilla Report for August 2009 -- Health Care Grows Another 28,000 While Hospitals And Insurers Feel Painful Pinch
8. The MedZilla Report for July, 2009 - Health Care Creates 20,000 More Jobs As Economy Hits Insurers
9. The MedZilla Report: June 2009 Employment Outlook for Biotech/Pharma/Health
10. The MedZilla Report: May 2009 Employment Outlook for Biotech/Pharma/Health
11. The MedZilla Report: April 2009 Employment Outlook for Biotech/Pharma/Health
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The MedZilla Report for April 2010 - Pharma Layoffs Drop Below 400 in March; Health Care Adds Another 27,000 Jobs
(Date:1/22/2015)... Jan. 22, 2015  Derma Sciences, Inc. (Nasdaq: ... on advanced wound care, announces that AMNIOEXCEL® and ... been added to the Premier, Inc. Regenerative Skin ... for the AMNIOEXCEL® and AMNIOMATRIX® product lines, which ...
(Date:12/24/2014)... AUSTIN, Texas , Dec. 24, 2014  Vermillion, ... focused on gynecologic disease, announced today that the ... investors including Oracle Investment Management, Jack W. ... directors. Total proceeds were $10.5 million, before offering ...
(Date:12/24/2014)... Earlier this year in a June 24 ... Adult Stem Cell Technology Center, LLC ( ASCTC ) focused ... of adult tissue stem cells. His title “Asymmetric Self-Renewal ... the Future,” embodied the essence of his message to congress ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 The ... as its definition, classification, application and industry overview. ... and product cost structure. Production is separated by ... upstream raw materials, equipment, downstream client survey, marketing ...
Breaking Biology Technology:Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... 17, 2011 Executives from NineSigma , Inc., the ... have written chapters on crucial elements of open innovation for ... Leading Experts. This bestselling book offers ... new solutions and capabilities outside of their organization and clearly ...
... and Ghent University have shown that a defective gene ... often-crippling inflammation of the joints that afflicts about 1% ... mechanism of the disease was largely unclear. In the ... demonstrate that a cell-specific defect in the expression of ...
... TARRYTOWN, N.Y., Aug. 16, 2011 Regeneron Pharmaceuticals, Inc. ... has received notification from the U.S. Food and Drug ... date to complete the priority review of the EYLEA ... age-related macular degeneration (wet AMD) to November 18, 2011, ...
Cached Biology Technology:From Leadership to Legal Issues, NineSigma Shares Best Practices in an Authoritative Guide to Open Innovation and CrowdSourcing 2Defect in A20 gene expression causes rheumatoid arthritis 2Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA 2Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA 3Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA 4
(Date:12/17/2014)... DUBLIN , Dec. 15, 2014 Research and Markets ... of the "Samsung Galaxy S5 - Home Button ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... the iPhone 5S, Samsung introduces for the first time ...
(Date:12/17/2014)... DENVER , Dec. 16, 2014  Automation is fundamentally ... evident than at international borders. Over the past decade, ... veteran travelers to self process through border control via ... increasing number of airports, seaports, and land borders across ...
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences International (DSI), ... released a new series of digital telemetry implants ... researchers. M series, part of the PhysioTel™ Digital ... best possible physiologic data when incorporating functional endpoints ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... , WASHINGTON, D.C., Dec. 15, 2011 Austen BioInnovation ... Drug Administration (FDA) have entered into a ground-breaking collaboration ... and effective use of biomaterials in medical devices. ... of Understanding that will allow the FDA to draw ...
... study has identified a gene mutation that researchers estimate dates ... disease mutation yet discovered. , Researchers with the Ohio State ... and Richard J. Solove Research Institute led the study and ... 13,600 years ago. Only a mutation seen in cystic fibrosis ...
... fetal exposure to carcinogens can vary substantially, a recent study ... depending on the stage of pregnancy when the fetus is ... in which toxic damage early in life can later manifest ... was done by scientists in the Linus Pauling Institute at ...
Cached Biology News:FDA, ABIA to collaborate on safety and performance of materials used in medical devices 2Scientists discover second-oldest gene mutation 2Cancer from fetal exposure to carcinogens depends on dose, timing 2
... DNA polymerase from Thermus aquaticus expressed in ... 1 tube of 250 units enzyme/tube and ... DNA), is the same enzyme as AmpliTaq ... a proprietary separation process to ensure that ...
... 5 units/µL ,• High specific activity and ... an 'A' overhang ,• Processes ... very high activity in primer extension and ... quality of the enzyme, each lot has ...
... AmpliTaq DNA Polymerase is the most thoroughly ... a testimony to its overall utility and ... it ideal for PCR applications. , ... results. ,, AmpliTaq DNA Polymerase is ...
Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/uL; 25 tubes of 1, 000 units enzyme/tube w/ Buffer I...
Biology Products: